Reversible Male Contraception
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
25
NCT05134428
A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0
Phase: N/A
Role: Lead Sponsor
Start: May 20, 2022
Completion: Feb 20, 2026
Loading map...